232 related articles for article (PubMed ID: 24848920)
21. [Tamoxifen and breast cancer].
Nechushtan H; Peretz T
Harefuah; 2002 Aug; 141(8):718-20, 761, 760. PubMed ID: 12222137
[TBL] [Abstract][Full Text] [Related]
22. SERMs for the treatment and prevention of breast cancer.
Swaby RF; Sharma CG; Jordan VC
Rev Endocr Metab Disord; 2007 Sep; 8(3):229-39. PubMed ID: 17440819
[TBL] [Abstract][Full Text] [Related]
23. Drugs can reduce the incidence of breast cancer: now what?
Wozniak TF; Eppes PG; Wilson CT
Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
[No Abstract] [Full Text] [Related]
24. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
25. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen in postmenopausal women a safety perspective.
Robinson E; Kimmick GG; Muss HB
Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
[TBL] [Abstract][Full Text] [Related]
27. Controversy about uterine effects and safety of SERMs: the saga continues.
Goldstein SR
Menopause; 2002; 9(5):381-4. PubMed ID: 12218728
[TBL] [Abstract][Full Text] [Related]
28. Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.
Chu W; Fyles A; Sellers EM; McCready DR; Murphy J; Pal T; Narod SA
Carcinogenesis; 2007 Oct; 28(10):2139-42. PubMed ID: 17434921
[TBL] [Abstract][Full Text] [Related]
29. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
30. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
31. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
Pinkerton JV; Goldstein SR
Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
[TBL] [Abstract][Full Text] [Related]
32. Surveillance for endometrial cancer in women receiving tamoxifen.
Suh-Burgmann EJ; Goodman A
Ann Intern Med; 1999 Jul; 131(2):127-35. PubMed ID: 10419429
[TBL] [Abstract][Full Text] [Related]
33. Endometrial lesions after tamoxifen therapy in breast cancer women.
Maugeri G; Nardo LG; Campione C; Nardo F
Breast J; 2001; 7(4):240-4. PubMed ID: 11678801
[TBL] [Abstract][Full Text] [Related]
34. A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.
Dede M; Gezginç K; Ulubay M; Alanbay I; Güran S; Yenen M
Eur J Gynaecol Oncol; 2008; 29(2):200. PubMed ID: 18459568
[TBL] [Abstract][Full Text] [Related]
35. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
[TBL] [Abstract][Full Text] [Related]
36. Long-term "protective" effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients.
Markovitch O; Tepper R; Fishman A; Aviram R; Cohen I
Breast Cancer Res Treat; 2009 Jan; 113(2):321-6. PubMed ID: 18297393
[TBL] [Abstract][Full Text] [Related]
37. A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials.
Smith RE
Semin Oncol; 2003 Oct; 30(5 Suppl 16):4-13. PubMed ID: 14613021
[TBL] [Abstract][Full Text] [Related]
38. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
39. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
40. Antiestrogenic therapy in breast cancer and endometrial modifications.
Mossa B; Marziani R; Hannuna K; Iuele T; Melluso J; Napolitano C
Eur J Gynaecol Oncol; 2005; 26(1):99-102. PubMed ID: 15755012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]